BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33203426)

  • 1. Early palliative radiation versus observation for high-risk asymptomatic or minimally symptomatic bone metastases: study protocol for a randomized controlled trial.
    Rosen DB; Benjamin CD; Yang JC; Doyle C; Zhang Z; Barker CA; Vaynrub M; Yang TJ; Gillespie EF
    BMC Cancer; 2020 Nov; 20(1):1115. PubMed ID: 33203426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.
    Rothrock RJ; Ozair A; Avendano MC; Herrera S; Appel H; Ramos S; Starosciak AK; Leon-Ariza DS; Rubens M; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha RR
    Trials; 2024 Jan; 25(1):41. PubMed ID: 38217032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
    Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
    Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
    Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
    BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control.
    Tseng YD
    Semin Radiat Oncol; 2023 Apr; 33(2):139-147. PubMed ID: 36990631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced toxicity after image-guided and intensity-modulated radiotherapy versus external beam radiotherapy for patients with spinal bone metastases (IRON-1): a study protocol for a randomized controlled pilot trial.
    Meyerhof E; Sprave T; Welte SE; Nicolay NH; Förster R; Bostel T; Bruckner T; Schlampp I; Debus J; Rief H
    Trials; 2017 Mar; 18(1):98. PubMed ID: 28253920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
    Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
    BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol.
    Olson R; Schlijper R; Chng N; Matthews Q; Arimare M; Mathews L; Hsu F; Berrang T; Louie A; Mou B; Valev B; Laba J; Palma D; Schellenberg D; Lefresne S
    BMC Cancer; 2019 Oct; 19(1):1011. PubMed ID: 31660894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis: a study protocol for the three armed randomized controlled FURTHER trial.
    Slotman DJ; Bartels MMTJ; Ferrer CJ; Bos C; Bartels LW; Boomsma MF; Phernambucq ECJ; Nijholt IM; Morganti AG; Siepe G; Buwenge M; Grüll H; Bratke G; Yeo SY; Blanco Sequeiros R; Minn H; Huhtala M; Napoli A; De Felice F; Catalano C; Bazzocchi A; Gasperini C; Campanacci L; Simões Corrêa Galendi J; Müller D; Braat MNGJA; Moonen C; Verkooijen HM;
    Trials; 2022 Dec; 23(1):1061. PubMed ID: 36582001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy for palliation of symptoms in incurable cancer.
    Hoegler D
    Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
    McDonald R; Ding K; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chan S; Chow E
    JAMA Oncol; 2017 Jul; 3(7):953-959. PubMed ID: 28196208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial.
    Sprave T; Welte SE; Bruckner T; Förster R; Bostel T; Schlampp I; Nicolay NH; Debus J; Rief H
    Trials; 2018 Jan; 19(1):59. PubMed ID: 29357902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
    Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
    Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic overview of radiation therapy effects in skeletal metastases.
    Falkmer U; Järhult J; Wersäll P; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):620-33. PubMed ID: 14596519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design.
    van der Velden JM; Verkooijen HM; Seravalli E; Hes J; Gerlich AS; Kasperts N; Eppinga WS; Verlaan JJ; van Vulpen M
    BMC Cancer; 2016 Nov; 16(1):909. PubMed ID: 27871280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.
    Gillespie EF; Yang JC; Mathis NJ; Marine CB; White C; Zhang Z; Barker CA; Kotecha R; McIntosh A; Vaynrub M; Bartelstein MK; Mitchell A; Guttmann DM; Yerramilli D; Higginson DS; Yamada YJ; Kohutek ZA; Powell SN; Tsai J; Yang JT
    J Clin Oncol; 2024 Jan; 42(1):38-46. PubMed ID: 37748124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).
    Mercier C; Dirix P; Ost P; Billiet C; Joye I; Vermeulen P; Lievens Y; Verellen D
    BMC Cancer; 2019 Sep; 19(1):876. PubMed ID: 31484505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs).
    Shulman RM; Meyer JE; Li T; Howell KJ
    Ann Palliat Med; 2019 Apr; 8(2):159-167. PubMed ID: 30525770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
    Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
    Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.